H Ben-Israel, T Kleinberger - Front Biosci, 2002 - researchgate.net
Introduction 3. The E1A proteins 3.1. Early findings 3.2. Targeting the pRb checkpoint by E1A 3.2. 1. pRb 3.2. 2. pRb family members 3.3. Targeting cyclin-Cdks by E1A 3.4. E1A …
Y Jiang, HI Saavedra, MP Holloway, G Leone… - Journal of Biological …, 2004 - ASBMB
Survivin is a putative oncogene that is aberrantly expressed in cancer cells. It has been hypothesized to play a central role in cancer progression and resistance to therapy in …
Terminal differentiation exerts a remarkably tight control on cell proliferation. However, the oncogenic products of DNA tumor viruses, such as adenovirus E1A, can force postmitotic …
Despite extensive study of human adenovirus type 5 E1A, surprisingly little is known about the E1A proteins of other adenoviruses. We report here a comprehensive analysis of the …
S Su, JT Minges, G Grossman, AJ Blackwelder… - Journal of Biological …, 2013 - ASBMB
Melanoma antigen-A11 (MAGE-A11) is a low-abundance, primate-specific steroid receptor coregulator in normal tissues of the human reproductive tract that is expressed at higher …
Mutation of the adenomatous polyposis coli and β-catenin genes in colon cancer leads to constitutive activation of transcription from promoters containing binding sites for Tcf/LEF …
Current oncolytic virotherapy strategies are based in the accumulated understanding of the common molecular mechanisms displayed during cell transformation and viral infection, like …
D Rosner, N McCarthy, M Bennett - Cardiovascular research, 2005 - academic.oup.com
Objective: Drug-eluting stents containing the immunosuppressant rapamycin markedly inhibit in stent restenosis (ISR). However, the molecular mechanisms that underlie its effect …